1. Home
  2. HFWA vs JANX Comparison

HFWA vs JANX Comparison

Compare HFWA & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Financial Corporation

HFWA

Heritage Financial Corporation

N/A

Current Price

$28.51

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

N/A

Current Price

$17.37

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HFWA
JANX
Founded
1927
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
HFWA
JANX
Price
$28.51
$17.37
Analyst Decision
Buy
Strong Buy
Analyst Count
6
18
Target Price
$32.60
★ $33.81
AVG Volume (30 Days)
286.5K
★ 751.0K
Earning Date
10-22-2026
11-09-2026
Dividend Yield
★ 3.46%
N/A
EPS Growth
★ 58.06
N/A
EPS
★ 0.90
N/A
Revenue
N/A
★ $10,000,000.00
Revenue This Year
$36.72
$194.24
Revenue Next Year
$7.95
N/A
P/E Ratio
$32.11
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$21.32
$12.12
52 Week High
$31.25
$35.34

Technical Indicators

Market Signals
Indicator
HFWA
JANX
Relative Strength Index (RSI) 54.10 51.36
Support Level $26.49 $15.90
Resistance Level $28.95 $19.16
Average True Range (ATR) 0.58 0.83
MACD 0.16 0.07
Stochastic Oscillator 66.72 48.72

Price Performance

Historical Comparison
HFWA
JANX

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company, through its subsidiary, provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as non-interest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: